Vir Biotechnology, Inc. (VIR)


Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Vir Biotechnology, Inc. chart...

About the Company

We do not have any company description for Vir Biotechnology, Inc. at the moment.

Exchange

Nasdaq

$86M

Total Revenue

562

Employees

$1B

Market Capitalization

-1.74

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VIR News

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors

4d ago, source: Stockhouse

Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its ...

Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle

7d ago, source: STAT

Vir Biotechnology's founders threw millions at infectious disease. Covid made them look like geniuses. The road since then ...

How Vir found the one: CEO Marianne De Backer

3d ago, source: FierceBiotech

Vir Biotechnology conducted a worldwide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne De Backer, Ph.D., because of her three decades of experience in the ...

Vir Biotechnology CFO Sung Lee to step down in May

5d ago, source: Investing

Vir Biotechnology Inc . (NASDAQ:VIR) announced Monday that Executive Vice President and Chief Financial Officer Sung Lee will resign from his position effective May 3, 2024. Lee is leaving to ...

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024

11d ago, source: Business Wire

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter e ...

Vir Biotechnology nominates two new board members

4d ago, source: Investing

SAN FRANCISCO - Vir Biotechnology, Inc. (NASDAQ:VIR), an immunology company specializing in infectious diseases, announced the nomination of two new independent directors to its Board of Directors.

Vir Biotechnology Inc

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors

5d ago, source: Yahoo Finance

SAN FRANCISCO, April 18, 2024--(BUSINESS WIRE)--Vir Biotechnology, Inc. ("Vir" or "the Company", Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid ...

Vir Biotechnology nominates two new board members

4d ago, source: Investing

SAN FRANCISCO - Vir Biotechnology, Inc. (NASDAQ:VIR), an immunology company specializing in infectious diseases, announced the nomination of two new independent directors to its Board of Directors. If ...

Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors

4d ago, source: ADVFN

Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the “Board ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...